HLN
Haleon plc
- PER (TTM)
- 18.22
- PER (Forward)
- 14.93
- EPS (TTM)
- -
- EPS (Forward)
- -
- PBR
- 1.81
- 시가총액
- 40.43B
- 배당수익률
- 209.00%
- 베타
- 0.25
- 1개월 수익률
- -7.78%
- 3개월 수익률
- -15.93%
- 6개월 수익률
- -0.85%
- 1년 수익률
- -13.69%
- 2년 수익률
- -
- 5일 평균거래량
- 13869640
- 60일 평균거래량
- 8819702
- 1년 평균거래량
- 10408971
- 5d/60d 거래량 비율
- 1.57×
- 60d/1y 거래량 비율
- 0.85×
- 변동성(60일, 연환산)
- 24.47%
- BB 스퀴즈 스코어
- 0.92
- SMA50 비율
- 0.93
- SMA200 비율
- 0.94
- RSI (14)
- 35
- 20일 수렴도
- 0.02
- 52주 최고
- 11.19
- 52주 최저
- 8.61
- 고점 대비
- -18.60%
- 저점 대비
- 5.86%
펀더멘털 갱신: 2026-05-10T09:23:39+00:00 · 시세 갱신: 2026-05-10T06:40:32+00:00
회사 정보
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.